ACTA2 and cancer: Among the remaining 75.2% of cells, transcripts for cytoplasmic CAF markers established in other cancers were robustly expressed, including actin alpha 2 (ACTA2) (18) and COL1A1 (19), expressed in 73.8% and 96.5% of cells, respectively.